NMS · Medical - Healthcare Information Services

SPOK (SPOK) Stock

$10.81 +2.08% NMS: SPOK Healthcare

Valuation

MetricValue
Price$10.81
Market Cap$225.79M
P/E Ratio14.72
P/B Ratio1.58
P/S Ratio1.68
EPS (TTM)$0.75
52-Week High$19.31
52-Week Low$9.95
Dividend Yield11.34%

Financials & Margins

MetricValue
ROE10.96%
ROA7.77%
ROCE13.70%
Gross Margin14.29%
Operating Margin14.29%
Net Margin9.27%
Debt/Equity0.04
Current Ratio1.18

Annual Financials (USD)

Metric20212022202320242025
Revenue$142.0M$135.0M$139.0M$138.0M$140.0M
Operating Profit$-12.0M$8.0M$22.0M$19.0M$20.0M
Net Profit$-22.0M$22.0M$16.0M$15.0M$16.0M
EPS$-1.14$1.09$0.77$0.73$0.75
Op Margin-8.5%5.6%15.7%13.8%14.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$248.0M$244.0M$228.0M$217.0M$206.0M
Total Liabilities$74.0M$72.0M$64.0M$62.0M$60.0M
Cash$45.0M$36.0M$32.0M$29.0M$25.0M
Borrowings$17.0M$16.0M$11.0M$9.0M$7.0M

Latest News

Spok to Sell Spectrum Licenses for $8 Million MT Newswires · Jun 24, 2026 Spok Announces Sale of Spectrum Licenses to Sensus Business Wire · Jun 24, 2026 Preferred Bank And 2 Other Dividend Stocks To Boost Your Portfolio Simply Wall St. · Jun 15, 2026 3 Dividend Stocks To Consider For Your Portfolio Simply Wall St. · May 15, 2026 Spok Q1 Earnings Call Highlights MarketBeat · Apr 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$8.0M$6.0M$26.0M$29.0M$29.0M
Investing Cash Flow$-15.0M$7.0M$-7.0M$-6.0M$-7.0M
Financing Cash Flow$-2.0M$-1.0M$-1.0M$-2.0M$-3.0M
Net Cash Flow$-4.0M$-9.0M$-4.0M$-3.0M$-4.0M
Free Cash Flow$-7.0M$3.0M$23.0M$26.0M$25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA9.24
FCF Yield11.09%
Quick Ratio1.09
Interest Coverage—
Return 1Y-34.80%
Return 3Y20.21%
Return 5Y97.20%

Ownership

Insiders Held2.40%
Institutions Held56.42%
Institutions Float Held57.81%
Institutional HolderSharesReport Date
Blackrock Inc.1,676,2272026-03-31
Renaissance Technologies, LLC1,261,5792026-03-31
Vanguard Capital Management LLC859,5302026-03-31
Dimensional Fund Advisors LP715,8692026-03-31
Geode Capital Management, LLC545,7182026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CERS $2.32 +2.20% -34.25 $467.54M 0.00%
CGC $0.92 +4.02% -0.20 $390.20M 0.00%
DH $0.67 -1.38% 4.29 $71.08M 0.00%
MASS $8.30 -1.31% 12.81 $340.53M 0.00%
NRC $18.30 -18.08% 36.21 $412.42M 2.98%

About SPOK

SPOK is led by CEO Vincent D. Kelly, employs 418 people, headquartered in US, publicly traded since 2004.

SPOK stock trades at $10.81 with a market capitalization of $225.79M. The stock is valued at a price-to-earnings (P/E) ratio of 14.72, price-to-book of 1.58, price-to-sales of 1.68. Over the past 52 weeks the stock has ranged between $9.95 and $19.31, and currently trades 44.0% below its 52-week high. It pays a dividend yielding 11.34%.

On profitability, SPOK generates a return on equity (ROE) of 10.96%, return on capital employed of 13.70%, an operating margin of 14.29%, a net profit margin of 9.27%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides